Sun Pharmaceutical Secures Top Credit Ratings Amid Acquisition Plans
Sun Pharmaceutical receives credit ratings from CRISIL and ICRA
Business Standard
Image: Business Standard
Sun Pharmaceutical Industries has received reaffirmed credit ratings from CRISIL and ICRA, with CRISIL maintaining a long-term rating of AAA and short-term rating of A1+. These ratings come in light of Sun Pharma's planned acquisition of Organon & Co., which is under review for its potential impact.
- 01CRISIL reaffirmed Sun Pharma's long-term rating at AAA and short-term rating at A1+.
- 02The long-term rating is on 'Rating Watch with Developing Implications' due to an upcoming acquisition.
- 03ICRA also reaffirmed Sun Pharma's long-term rating at AAA and short-term rating at A1+.
- 04The ratings reflect confidence in Sun Pharma's financial stability and growth prospects.
- 05Final ratings will be announced post-assessment of the Organon & Co. acquisition.
Advertisement
In-Article Ad
Sun Pharmaceutical Industries (Sun Pharma) has received reaffirmed credit ratings from CRISIL and ICRA, reflecting strong confidence in its financial health. CRISIL maintains a long-term rating of AAA and a short-term rating of A1+, although the long-term rating is currently on 'Rating Watch with Developing Implications' due to Sun Pharma's announcement on April 27, 2026, regarding its agreement to acquire Organon & Co. CRISIL will finalize its rating after a thorough evaluation of this acquisition. Meanwhile, ICRA has also reaffirmed Sun Pharma's long-term rating at AAA with a Stable outlook and a short-term rating of A1+. These ratings indicate a robust financial position and growth potential for Sun Pharma in the pharmaceutical industry.
Advertisement
In-Article Ad
The reaffirmed ratings suggest that Sun Pharma is in a strong position to pursue growth opportunities, potentially leading to job stability and investment in the local economy.
Advertisement
In-Article Ad
Reader Poll
Do you think the acquisition of Organon & Co. will benefit Sun Pharmaceutical?
Connecting to poll...
More about Sun Pharmaceutical Industries
Read the original article
Visit the source for the complete story.